Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2023-02-15 00:00:00 ET · period of report 2023-02-13 · accession 0001714899-23-000029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-02-15 | 2023-02-13 | DNLI | Watts Ryan J. | Pres, CEO, Dir | M - OptEx | $0.68 | +25.0K | 2.26M | +1% | +$17.0K |
| DMI | 2023-02-15 | 2023-02-13 | DNLI | Watts Ryan J. | Pres, CEO, Dir | S - Sale+OE | $30.08 | -33.8K | 2.24M | -1% | -$1.02M |
| D | 2023-02-15 | 2023-02-13 | DNLI | Watts Ryan J. | Pres, CEO, Dir | M - OptEx | $0.00 | -25.0K | 1.20M | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-13 | M | A | 25,000 | $0.68 | 2,264,913 | I See footnote | — | — | (F4) The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. |
| 2 | Common | Common Stock | 2023-02-13 | S | D | 25,000 | $30.08 | 2,239,913 | I See footnote | — | — | (F6) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.26 per share. Upon request by the Commission staff, the Issuer, or asecurityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F4) The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. |
| 3 | Common | Common Stock | 2023-02-13 | S | D | 8,815 | $30.09 | 2,239,913 | I See footnote | — | — | (F2) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.95 to $30.24 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F3) Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 19,697 restricted stock units held by the Reporting Person. (F4) The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. |
| 4 | Derivative | Stock Option (right to buy) | 2023-02-13 | M | D | 25,000 | $0.00 | 1,195,617 | D | $0.68 · — to 2025-08-20 | 25,000 Common Stock | (F8) The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days. |